Cytokinetics Inc (CYTK) — Cash Flow-to-Debt Ratio
Cytokinetics Inc (CYTK) has a Cash Flow-to-Debt Ratio of -0.07x as of March 2026, meaning its operating cash flow of $-145.46 Million could theoretically repay 0% of its total liabilities ($2.10 Billion) in one year. Explore investment intensity of Cytokinetics Inc to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cytokinetics Inc Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for Cytokinetics Inc across 24 annual periods. Also explore Cytokinetics Inc assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Cytokinetics Inc (2002–2025)
Year-by-year debt coverage analysis for Cytokinetics Inc. For market capitalisation and broader financial context, see Cytokinetics Inc (CYTK) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.24x | $-510.01 Million | $2.08 Billion | ▲ +5.0% |
| 2024 | -0.26x | $-395.89 Million | $1.54 Billion | ▲ +24.7% |
| 2023 | -0.34x | $-414.33 Million | $1.21 Billion | ▼ -28.3% |
| 2022 | -0.27x | $-299.52 Million | $1.12 Billion | ▼ -11.8% |
| 2021 | -0.24x | $-142.52 Million | $597.46 Million | ▼ -1221.4% |
| 2020 | 0.02x | $8.94 Million | $420.42 Million | ▲ +107.0% |
| 2019 | -0.30x | $-90.91 Million | $300.75 Million | ▲ +44.7% |
| 2018 | -0.55x | $-101.22 Million | $185.24 Million | ▲ +0.7% |
| 2017 | -0.55x | $-101.76 Million | $184.97 Million | ▼ -212.7% |
| 2016 | 0.49x | $36.98 Million | $75.78 Million | ▲ +366.2% |
| 2015 | 0.10x | $4.88 Million | $46.65 Million | ▲ +109.5% |
| 2014 | -1.10x | $-44.84 Million | $40.90 Million | ▼ -308.3% |
| 2013 | -0.27x | $-7.72 Million | $28.75 Million | ▲ +95.1% |
| 2012 | -5.47x | $-33.44 Million | $6.11 Million | ▲ +44.9% |
| 2011 | -9.92x | $-45.59 Million | $4.59 Million | ▼ -65.5% |
| 2010 | -6.00x | $-44.83 Million | $7.48 Million | ▼ -1608.4% |
| 2009 | 0.40x | $8.42 Million | $21.17 Million | ▲ +124.4% |
| 2008 | -1.63x | $-61.33 Million | $37.69 Million | ▼ -2902.9% |
| 2007 | -0.05x | $-3.00 Million | $55.45 Million | ▲ +92.7% |
| 2006 | -0.75x | $-47.17 Million | $63.20 Million | ▲ +66.2% |
| 2005 | -2.21x | $-39.48 Million | $17.90 Million | ▼ -33.2% |
| 2004 | -1.66x | $-34.03 Million | $20.55 Million | ▼ -740.9% |
| 2003 | -0.20x | $-30.51 Million | $154.90 Million | ▼ -3.1% |
| 2002 | -0.19x | $-22.30 Million | $116.76 Million | — |